Abstract
Molecular mechanisms regulating lymphangiogenesis may be exploited as potential treatments for disorders of lymphatic circulation.
MeSH terms
-
Animals
-
Blood Circulation
-
Cell Differentiation / genetics
-
Cell Differentiation / physiology
-
ELAV Proteins / genetics
-
ELAV Proteins / physiology
-
Endothelium, Vascular / cytology
-
Endothelium, Vascular / physiology
-
Homeodomain Proteins / genetics
-
Homeodomain Proteins / metabolism
-
Humans
-
Lymphangiogenesis / genetics
-
Lymphangiogenesis / physiology*
-
Lymphatic Vessels / anatomy & histology
-
Lymphatic Vessels / embryology*
-
Lymphatic Vessels / physiology
-
Lymphedema / physiopathology
-
Lymphedema / therapy*
-
Mice
-
RNA Stability
-
SOXF Transcription Factors / genetics
-
SOXF Transcription Factors / metabolism
-
Tumor Suppressor Proteins / genetics
-
Tumor Suppressor Proteins / metabolism
-
Vascular Endothelial Growth Factor A / genetics
-
Vascular Endothelial Growth Factor A / metabolism
-
Vascular Endothelial Growth Factor C / genetics
-
Vascular Endothelial Growth Factor C / metabolism
-
Vascular Endothelial Growth Factor Receptor-3 / metabolism
-
Veins / embryology
-
Veins / physiology
Substances
-
ELAV Proteins
-
Homeodomain Proteins
-
SOXF Transcription Factors
-
Tumor Suppressor Proteins
-
Vascular Endothelial Growth Factor A
-
Vascular Endothelial Growth Factor C
-
prospero-related homeobox 1 protein
-
Vascular Endothelial Growth Factor Receptor-3